Ractigen Therapeutics

Ractigen Therapeutics is a drug discovery company in Suzhou, China, founded in 2017. It has raised $78.0M across 3 rounds, most recently a $31.0M Venture Round in July 2026.

Headquarters
Suzhou, Jiangsu
Employees
51–200
Founded
2017
Total Funding
$78.0M
Last Round
$31.0M Venture RoundJul 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 2 investors for this company. The full record is or through the API.

About

Ractigen Therapeutics is a clinical-stage pharmaceutical company specializing in developing pioneering therapies aimed at enhancing the expression of therapeutic genes within diseased cells. Founded in 2017 by trailblazers in RNA activation (RNAa) research, the company builds on a foundational discovery at the University of California, San Francisco (UCSF) to create duplex saRNA therapeutics that target diseases arising from inadequate gene expression. Its main headquarters is located in the bioBAY area of Suzhou, spanning 2200 square meters with certified BSL-2 biology laboratories, alongside an oligonucleotide manufacturing facility in Rudong, Jiangsu, and a business development office in Shanghai.

Summary

It lists 51–200 employees. It has raised $78.0M in total across 3 rounds, most recently a $31.0M Venture Round in Jul 2026. Investors include SDIC Venture Capital and Huimei Capital.

Funding History

Data from Indexed.vcUpdated
$31.0M

Sign up to see all 3 events

Funding: Series A through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Shields Health Solutions

The nation's first company to integrate specialty pharmacies into hospitals and health systems, h...

United StatesHealthcare, Drug Discovery
Corporate RoundTotal funding$3.5BSep 2025
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ractigen Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/ractigen-therapeutics"><img src="https://indexed.vc/api/badge/company/ractigen-therapeutics" alt="Ractigen Therapeutics on Indexed.vc" width="260" height="76" /></a>